Lataa...
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia
Purpose of review Core-binding factor (CBF) acute myeloid leukemia (AML) is among the most common cytogenetic subtypes of AML, being detected in approximately 13% of adults with primary disease. Although CBF-AML is associated with a relatively favorable prognosis, only one-half of the patients are c...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3677535/ https://ncbi.nlm.nih.gov/pubmed/18841055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e32831369df |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|